Sotera Health to Present at the 42nd Annual J.P. Morgan Healthcare Conference
CLEVELAND, Jan. 03, 2024 (GLOBE NEWSWIRE) — Sotera Health Company (“Sotera Health” or the “Company”) (NASDAQ: SHC), a leading global […]
iTeos to Present at the 42nd Annual J.P. Morgan Healthcare Conference
WATERTOWN, Mass. and GOSSELIES, Belgium, Jan. 03, 2024 (GLOBE NEWSWIRE) — iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company […]
Liquidity Services Acquires Sierra Auction, a Leading Auctioneer of Vehicles, Equipment, and Surplus Assets for Government and Commercial Organizations
BETHESDA, Md., Jan. 03, 2024 (GLOBE NEWSWIRE) — Liquidity Services, Inc. (NASDAQ: LQDT), a leading global commerce company powering the […]
Entrada Therapeutics Promotes Nathan J. Dowden to President
– With a proven track record at Entrada and across his 30-year career in the healthcare sector, Mr. Dowden is well-positioned […]
Editas Medicine to Present at the 42nd Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing company, today announced […]
SEALSQ To Launch SEALCOIN, a digital token and advanced cryptocurrency protocol, at the Davos Space IoT and Cybersecurity Event on January 17, 2024
Tortola, British Virgin Islands, Jan. 03, 2024 (GLOBE NEWSWIRE) — January 3, 2024: SEALSQ Corp (“SEALSQ” or “Company”) (NASDAQ: LAES), […]
Voyager Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
LEXINGTON, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic […]
BioCardia Biotherapeutic Delivery and Morph Access Innovations Business Development Update for Shareholders
SUNNYVALE, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) — BioCardia, Inc. (Nasdaq: BCDA), a developer of cellular and cell-derived therapeutics for the […]
InspireMD Announces Appointment of Medical Technology Executive Pete Ligotti as Executive Vice President and General Manager of North America
Appointment brings more than 30 years of medical technology general management and commercial leadership experience to the InspireMD team Reports […]
Amicus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
PRINCETON, N.J., Jan. 03, 2024 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD) today announced that Bradley Campbell, President and Chief […]
